Insights on the Mechanical Properties of SARS-CoV-2 Particles and the Effects of the Photosensitizer Hypericin
- PMID: 39201411
- PMCID: PMC11354238
- DOI: 10.3390/ijms25168724
Insights on the Mechanical Properties of SARS-CoV-2 Particles and the Effects of the Photosensitizer Hypericin
Abstract
SARS-CoV-2 is a highly pathogenic virus responsible for the COVID-19 disease. It belongs to the Coronaviridae family, characterized by a phospholipid envelope, which is crucial for viral entry and replication in host cells. Hypericin, a lipophilic, naturally occurring photosensitizer, was reported to effectively inactivate enveloped viruses, including SARS-CoV-2, upon light irradiation. In addition to its photodynamic activity, Hyp was found to exert an antiviral action also in the dark. This study explores the mechanical properties of heat-inactivated SARS-CoV-2 viral particles using Atomic Force Microscopy (AFM). Results reveal a flexible structure under external stress, potentially contributing to the virus pathogenicity. Although the fixation protocol causes damage to some particles, correlation with fluorescence demonstrates colocalization of partially degraded virions with their genome. The impact of hypericin on the mechanical properties of the virus was assessed and found particularly relevant in dark conditions. These preliminary results suggest that hypericin can affect the mechanical properties of the viral envelope, an effect that warrants further investigation in the context of antiviral therapies.
Keywords: AFM-fluorescence correlative microscopy; Atomic Force Microscopy (AFM); SARS-CoV-2; enveloped viruses; hypericin; nanomechanical properties; photodynamic therapy (PDT).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
The potential of metal-organic framework MIL-101(Al)-NH2 in the forefront of antiviral protection of cells via interaction with SARS-CoV-2 spike RBD protein and their antibacterial action mediated with hypericin and photodynamic treatment.J Colloid Interface Sci. 2025 Aug;691:137454. doi: 10.1016/j.jcis.2025.137454. Epub 2025 Mar 26. J Colloid Interface Sci. 2025. PMID: 40168900
-
The Interaction of Hypericin with SARS-CoV-2 Reveals a Multimodal Antiviral Activity.ACS Appl Mater Interfaces. 2022 Mar 30;14(12):14025-14032. doi: 10.1021/acsami.1c22439. Epub 2022 Mar 18. ACS Appl Mater Interfaces. 2022. PMID: 35302731 Free PMC article.
-
Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.Sci Rep. 2021 Jun 4;11(1):11885. doi: 10.1038/s41598-021-91371-4. Sci Rep. 2021. PMID: 34088957 Free PMC article.
-
Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.Curr Drug Targets. 2002 Feb;3(1):55-84. doi: 10.2174/1389450023348091. Curr Drug Targets. 2002. PMID: 11899265 Review.
-
Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.Molecules. 2020 Dec 1;25(23):5666. doi: 10.3390/molecules25235666. Molecules. 2020. PMID: 33271809 Free PMC article. Review.
Cited by
-
Membrane-Targeting Antivirals.Int J Mol Sci. 2025 Jul 28;26(15):7276. doi: 10.3390/ijms26157276. Int J Mol Sci. 2025. PMID: 40806409 Free PMC article. Review.
References
-
- Modrow S., Falke D., Truyen U., Schätzl H., editors. Molecular Virology. Springer; Berlin/Heidelberg, Germany: 2013. Viruses with Single-Stranded, Positive-Sense RNA Genomes; pp. 185–349.
-
- Malik Y.A. Properties of Coronavirus and SARS-CoV-2. Malays. J. Pathol. 2020;42:3–11. - PubMed
MeSH terms
Substances
Grants and funding
- B53C22001810006, IR0000023/EU funding within the NextGenerationEU-MUR PNRR infrastructure initiative SEE-LIFE "StrEngthEning the ItaLIan InFrastructure of Eurobioimaing"
- PE00000007, INF-ACT/EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
- CN00000041/EU funding within the NextGenerationEU-MUR PNRR "National Center for Gene Therapy and Drugs based on RNA Technology"
- COC-1- 2023-CNR/INF-ACT Cascade Open Call 2023
LinkOut - more resources
Full Text Sources
Miscellaneous